Andere talen CKD Bio Corp.

Aandelen

A063160

KR7063160006

slotkoers Korea S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
24.000 ^KRW	-0,41%		-0,83%	+0,63%

2023	CKD Bio Corp. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI
2023	CKD Bio Corp. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea	27/02
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index	18-09-23
CKD Bio Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
CKD Bio Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16-08-22
CKD Bio Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	16-05-22
CKD Bio Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	17-03-22
CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15-11-21
Exclusive: South Korea's GL Rapha to ship out 10 million Sputnik Light COVID-19 shots this month	14-09-21
Boryung Pharmaceutical : S.Korea's GL Rapha to ship out 10 mln Sputnik Light COVID-19 shots this month	14-09-21
CKD Bio Corp.(KOSE:A063160) added to S&P Global BMI Index	21-09-20
Chong Kun Dang Holdings Corp. completed the acquisition of additional 35.67% stake in Ckd Bio Corporation for KRW 61.6 billion.	12-07-16
Chong Kun Dang Holdings Corp. made an offer to acquire an additional 35.67% stake in Ckd Bio Corporation for KRW 55.9 billion.	19-05-16
Korea Securities Finance Corporation acquired 4.11% stake in Ckd Bio Corporation.	09-01-15
Ckd Bio Corporation Announces Earnings Results for the Full Year Ended December 31, 2012	20-05-13

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Ontdek onze gratis inhoud om de beurs beter te leren begrijpen.

Gratis inschrijven

fermer